Below are articles from various sources about members of MCB and their research.
Congratulations to MCB graduating seniors Samantha Hao and Yvonne Hao, 2019 University Medal runners-up!
The University Medal winner and runners-up are graduating seniors who embody the highest ideals of UC Berkeley, including outstanding scholarship, perseverance, and impacting the lives of others.
30 years ago, Berkeley was a much different place. The cost of in-state tuition for undergraduates was less than $1,500 a year, the median rent was $392, and the spaces which now hold Life Sciences Addition and Koshland Hall were UC Berkeley parking lots.
Much like campus buildings and rent prices, molecular biology at Berkeley has transformed immensely since 1989. That year, UC Berkeley consolidated more than 10 departments that focused on aspects of molecular biology and formed the Molecular and Cell Biology department as it is known today. Since then, from the discovery of cellular membrane trafficking to breakthroughs in cancer immunotherapy to the advent of the CRISPR revolution, the people of UC Berkeley MCB have been at the forefront of innovation in biology.
Congratulations to MCB Professor Matthew Welch, the next editor-in-chief of ASCB's online basic scientific research journal, Molecular Biology of the Cell.
Welch will succeed current editor-in-chief and fellow MCB Professor David Drubin in January 2020.
Congratulations to MCB Professors Rebecca Heald and David Raulet for being elected members of the National Academy of Sciences! Members of the National Academy of Sciences are elected in recognition of their distinguished and continuing achievements in their original research.
On April 10, 2019, MCB Professor David Raulet gave a lecture on the revolution of cancer immunology for the Berkeley Talks series, sponsored by UC Berkeley's Osher Lifelong Learning Institute (OLLI).
"In this talk, Raulet describes how these medicines work, their current limitations and the prospects for novel and more effective immunotherapy approaches, including those based on research in his laboratory."
Listen here! (1 hour)
MCB has been busy this semester!
Read all about what MCB has been up to lately, from our recent research endeavors to our MCB 30 Alumni Symposuim!
YourChoice Therapeutics, a startup co-founded by MCB Associate Professor Polina Lishko, is developing the first hormone-free birth control for both men and women to be released in 2025.
The contraceptives were first developed in Lishko's lab, which focuses on the mammalian fertilization and molecular physiology of human sperm cells.
Congratulations to MCB Professor Kristin Scott for being elected a Fellow of the American Academy of Arts & Sciences! Scott studies the taste system in fruit flies to understand how sensory information is processed by the brain and linked to behavior.
Congratulations to MCB Professor & Senior Associate Dean of Biological Sciences Richard Harland, who is a newly elected Fellow of The Royal Society of London! Harland is a pioneer in the field of developmental biology whose major contributions to the field include understanding dorsal ventral patterning of the early embryo and the induction and patterning of the neural plate.
On April 11, the MCB Industrial Affiliates Program (IAP) Spring 2019 Symposium brought together industry and academia to offer UC Berkeley scientists at all career stages an opportunity to build direct connections with nine innovative biotechnology companies. The event was a great success, drawing students and postdoctoral scholars from several departments on campus including MCB, IB, Bioengineering, Biophysics, and Comparative Biochemistry. Continue reading >